Search Results 941-950 of 13936 for Assay

  1. Clinical trials - Oncology (Medical)

    ... assays using patient peripheral blood immune cells or serum. Pagination Clinical studies. PrevPrevious Page · Go to page 99 · Go to page 1010 · Go to page 1111 ...

  2. Thyroid Cancer Clinical Trials - Mayo Clinic Research

    GRAIL is using deep sequencing of circulating cell-free nucleic acids (cfNAs) to develop assays to detect cancer early in blood. The purpose of this study is to ...

  3. Clinical trials - Oncology (Medical)

    ... assays using patient peripheral blood immune cells or serum. Pagination Clinical studies. PrevPrevious Page · Go to page 99 · Go to page 1010 · Go to page 1111 ...

  4. A Study To Evaluate Tazemetostat And Pembrolizumab To Treat Advanced Urothelial Carcinoma - Mayo Clinic

    ... Assay companion diagnostic test and who have a combined positive score (CPS) of >= 10 may be eligible. In these cases, PD-L1 testing does not need to be ...

  5. A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Anti-N-Methyl-D-Aspartic Acid Receptor (NMDAR) Or Anti-Leucine-Rich Glioma-Inactivated 1 (LGI1) Encephalitis (Cielo) - Mayo Clinic

    ... assay within 9 months of symptom onset * Historically known positivity to an intracellular antigen with high cancer association or GAD-65 * Historically ...

  6. Clinical trials - Oncology (Medical)

    ... assays using patient peripheral blood immune cells or serum. Evaluate REC-4881 in Patients With FAP (TUPELO). Scottsdale/Phoenix, Ariz., Rochester, Minn. The ...

  7. Biology of Aging and Age-Related Diseases Laboratory - Mayo Clinic Research

    The research team is optimizing biomarker assays for human liver biopsy samples. Dr. Jurk's ultimate goal is to expand treatment options by advancing ...

  8. Clinical trials - Brain Tumor Program

    cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (CAMPERR). Rochester, Minn. The purpose of this ...

  9. A Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of HPN217 In Patients With Relaped/Refractory Multiple Myeloma - Mayo Clinic

    Serum free light chain (FLC) assay: Involved FLC level ≥10 mg/dL (≥ 100 mg/L). Eastern Cooperative Oncology Group (ECOG) performance status ≤ 2. Adequate ...

  10. A Study To Evaluate AL101 Monotherapy In Patients With Notch Activated Triple Negative Breast Cancer - Mayo Clinic

    ... assay, LDT or other validated IUO clinical trial assay. Women of childbearing potential (WOCBP) must have a negative serum or urine pregnancy test ...